Patents by Inventor Ran KANG

Ran KANG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Magnetic nano-drug with double targeting VEGF-VEGFR, and preparation method and application thereof
    Patent number: 12220413
    Abstract: The present disclosure provides a magnetic nano-drug with double targeting vascular endothelial growth factor (VEGF)-vascular endothelial growth factor receptor (VEGFR), and a preparation method and application thereof, and belongs to the technical field of biomedicine. The magnetic nano-drug of the present disclosure includes aminated ZnFe2O4 hollow porous magnetic nano-particles, lactate dehydrogenase-silk fibroin (LDH-SF), ethylene dichloride (EDC), and n-hydroxy succinimide (NHS). A mass ratio of the aminated ZnFe2O4 hollow porous magnetic nano-particles to the EDC to the NHS to the LDH-SF is (5-10):(1-5):(1-6):(1-8).
    Type: Grant
    Filed: July 8, 2024
    Date of Patent: February 11, 2025
    Assignee: The Third Clinical Medical College, Nanjing University of Chinese Medicine
    Inventors: Xin Liu, Ran Kang, Lin Xie, Congyang Xue, Bo Chen, Zihan Wang, Nan Wang, Liping Chen
  • MAGNETIC NANO-DRUG WITH DOUBLE TARGETING VEGF-VEGFR, AND PREPARATION METHOD AND APPLICATION THEREOF
    Publication number: 20250017920
    Abstract: The present disclosure provides a magnetic nano-drug with double targeting vascular endothelial growth factor (VEGF)-vascular endothelial growth factor receptor (VEGFR), and a preparation method and application thereof, and belongs to the technical field of biomedicine. The magnetic nano-drug of the present disclosure includes aminated ZnFe2O4 hollow porous magnetic nano-particles, lactate dehydrogenase-silk fibroin (LDH-SF), ethylene dichloride (EDC), and n-hydroxy succinimide (NHS). A mass ratio of the aminated ZnFe2O4 hollow porous magnetic nano-particles to the EDC to the NHS to the LDH-SF is (5-10):(1-5):(1-6):(1-8). The magnetic nano-drug according to the present disclosure can position a VEGF ligand through magnetic targeting of hollow zinc ferrite particles, use magnetic particles to regulate reprogramming of macrophages in an intervertebral disc so as to indirectly regulate down-regulation of the VEGF, and inhibit angiogenesis.
    Type: Application
    Filed: July 8, 2024
    Publication date: January 16, 2025
    Inventors: Xin LIU, Ran KANG, Lin XIE, Congyang XUE, Bo CHEN, Zihan WANG, Nan WANG, Liping CHEN
  • Electronic device for displaying screen according to user orientation and control method thereof
    Patent number: 10216469
    Abstract: Disclosed is a method of controlling an electronic device. The method may include: acquiring a user's location with respect to the electronic device; and determining a display direction of a screen displayed on the electronic device based on the acquired user's location and displaying a first screen in the determined display direction.
    Type: Grant
    Filed: April 1, 2016
    Date of Patent: February 26, 2019
    Assignee: Samsung Electronics Co., Ltd.
    Inventors: Ran Kang, Nam-Hoi Kim, Seong-Woong Park, Do-Hyung Lee
  • ELECTRONIC DEVICE FOR DISPLAYING SCREEN AND CONTROL METHOD THEREOF
    Publication number: 20160313963
    Abstract: Disclosed is a method of controlling an electronic device. The method may include: acquiring a user's location with respect to the electronic device; and determining a display direction of a screen displayed on the electronic device based on the acquired user's location and displaying a first screen in the determined display direction.
    Type: Application
    Filed: April 1, 2016
    Publication date: October 27, 2016
    Inventors: Ran KANG, Nam-Hoi KIM, Seong-Woong PARK, Do-Hyung LEE